World Stroke Organization Infographic on Antithrombotic Therapies for Ischemic Stroke Prevention
28 Jan 2026Infographic created in BioRender, C, A. (2025), © World Stroke Organization
Current Insights into Antithrombotic Therapies for Ischemic Stroke Prevention: Focus on Atherosclerotic Stroke Disease
Infographic created in BioRender, C, A. (2025), © World Stroke Organization
Introduction
Ischemic stroke remains a leading cause of disability and mortality worldwide, with atherosclerotic disease representing a major underlying mechanism. Preventing recurrent events in this population continues to be a clinical priority, requiring careful selection of antithrombotic strategies that balance efficacy and safety.
To support healthcare professionals in navigating this complex and evolving field, the World Stroke Academy has developed an educational infographic titled “Current Insights into Antithrombotic Therapies for Ischemic Stroke Prevention: Focus on Atherosclerotic Stroke Disease.” The infographic provides a concise, visual overview of current concepts and emerging perspectives in antithrombotic management for patients with atherosclerotic ischemic stroke.
Key educational themes
-
The pathophysiological role of atherosclerosis in ischemic stroke and its implications for secondary prevention
-
Current antithrombotic approaches used in clinical practice, with attention to antiplatelet strategies
-
Ongoing challenges in optimizing stroke prevention while minimizing bleeding risk
-
Areas of active research and future directions in antithrombotic therapy development
By presenting complex information in a clear and accessible format, the infographic aims to support evidence-based decision-making and stimulate reflection on how evolving data may shape future clinical practice. This educational resource is intended to complement existing guidelines and clinical judgment, rather than replace them, and encourages continued learning in a rapidly advancing therapeutic landscape.
Educational grant disclosure
This infographic and accompanying educational content were developed with the support of an unrestricted educational grant from Bayer AG which had no influence over the content selection, data interpretation, or editorial decisions. The views expressed are those of the authors and the World Stroke Academy.
→ Access full infographic here: Current Insights into Antithrombotic Therapies for Ischemic Stroke Prevention: Focus on Atherosclerotic Stroke Disease
Related education
Antithrombotic Therapy for Atherosclerotic Stroke Prevention: Current Insights & Future Perspectives
;
